Evaluation of treatment of hyperemesis gravidarum using parenteral fluid with or without diazepam. A randomized study

A. Ditto, G. Morgante, A. La Marca, Vincenzo De Leo

Research output: Contribution to journalArticle

Abstract

Objective: Hyperemesis gravidarum is a relatively unknown disease, and is generally self-limiting. In some women the symptoms are so severe as to threaten the health of the mother and fetus. Therapies proposed for hyperemesis gravidarum are therefore rather empirical. Medical treatment includes parenteral fluid replacement and nutrition, electrolytes, antiemetics, vitamins, sedation and psychological counseling. Diazepam and benzodiazepins have been widely studied in pregnancy but the results are contradictory. The aim of the present study was to investigate the efficacy of parenteral fluids with vitamins, with or without diazepam sedation. Methods: Fifty women with hyperemesis gravidarum were enrolled in the study. They were treated with infusions of normal saline, glucose, vitamins and randomly with diazepam. Results: The results show that the mean stay in the hospital was shorter in the diazepam group: 4.5 ± 1.9 vs. 6 ± 1.6 days (p <0.05) and readmission to the the hospital was 4% in the diazepam group versus 27% in other group (p <0.05). There was a significant reduction in nausea in the diazepam group (p <0.05). A significant reduction in vomiting was observed in both groups. No side effects or congenital neonatal malformations were found in the diazepam group. Conclusions: Intravenous administration of fluids and vitamins is the standard treatment for women hospitalized for hyperemesis gravidarum. The addition of diazepam to the treatment is effective in reducing nausea and does not have teratogenic effects.

Original languageEnglish
Pages (from-to)232-236
Number of pages5
JournalGynecologic and Obstetric Investigation
Volume48
Issue number4
Publication statusPublished - 1999

Fingerprint

Hyperemesis Gravidarum
Diazepam
Vitamins
Therapeutics
Nausea
Patient Readmission
Antiemetics
Intravenous Administration
Electrolytes
Vomiting
Counseling
Length of Stay
Fetus
Mothers
Psychology
Glucose
Pregnancy

Keywords

  • Diazepam
  • Hyperemesis gravidarum
  • Intravenous fluid therapy
  • Pregnancy

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Evaluation of treatment of hyperemesis gravidarum using parenteral fluid with or without diazepam. A randomized study. / Ditto, A.; Morgante, G.; La Marca, A.; De Leo, Vincenzo.

In: Gynecologic and Obstetric Investigation, Vol. 48, No. 4, 1999, p. 232-236.

Research output: Contribution to journalArticle

@article{af762e1482ec4fc59c02460187bb22c3,
title = "Evaluation of treatment of hyperemesis gravidarum using parenteral fluid with or without diazepam. A randomized study",
abstract = "Objective: Hyperemesis gravidarum is a relatively unknown disease, and is generally self-limiting. In some women the symptoms are so severe as to threaten the health of the mother and fetus. Therapies proposed for hyperemesis gravidarum are therefore rather empirical. Medical treatment includes parenteral fluid replacement and nutrition, electrolytes, antiemetics, vitamins, sedation and psychological counseling. Diazepam and benzodiazepins have been widely studied in pregnancy but the results are contradictory. The aim of the present study was to investigate the efficacy of parenteral fluids with vitamins, with or without diazepam sedation. Methods: Fifty women with hyperemesis gravidarum were enrolled in the study. They were treated with infusions of normal saline, glucose, vitamins and randomly with diazepam. Results: The results show that the mean stay in the hospital was shorter in the diazepam group: 4.5 ± 1.9 vs. 6 ± 1.6 days (p <0.05) and readmission to the the hospital was 4{\%} in the diazepam group versus 27{\%} in other group (p <0.05). There was a significant reduction in nausea in the diazepam group (p <0.05). A significant reduction in vomiting was observed in both groups. No side effects or congenital neonatal malformations were found in the diazepam group. Conclusions: Intravenous administration of fluids and vitamins is the standard treatment for women hospitalized for hyperemesis gravidarum. The addition of diazepam to the treatment is effective in reducing nausea and does not have teratogenic effects.",
keywords = "Diazepam, Hyperemesis gravidarum, Intravenous fluid therapy, Pregnancy",
author = "A. Ditto and G. Morgante and {La Marca}, A. and {De Leo}, Vincenzo",
year = "1999",
language = "English",
volume = "48",
pages = "232--236",
journal = "Gynecologic and Obstetric Investigation",
issn = "0378-7346",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Evaluation of treatment of hyperemesis gravidarum using parenteral fluid with or without diazepam. A randomized study

AU - Ditto, A.

AU - Morgante, G.

AU - La Marca, A.

AU - De Leo, Vincenzo

PY - 1999

Y1 - 1999

N2 - Objective: Hyperemesis gravidarum is a relatively unknown disease, and is generally self-limiting. In some women the symptoms are so severe as to threaten the health of the mother and fetus. Therapies proposed for hyperemesis gravidarum are therefore rather empirical. Medical treatment includes parenteral fluid replacement and nutrition, electrolytes, antiemetics, vitamins, sedation and psychological counseling. Diazepam and benzodiazepins have been widely studied in pregnancy but the results are contradictory. The aim of the present study was to investigate the efficacy of parenteral fluids with vitamins, with or without diazepam sedation. Methods: Fifty women with hyperemesis gravidarum were enrolled in the study. They were treated with infusions of normal saline, glucose, vitamins and randomly with diazepam. Results: The results show that the mean stay in the hospital was shorter in the diazepam group: 4.5 ± 1.9 vs. 6 ± 1.6 days (p <0.05) and readmission to the the hospital was 4% in the diazepam group versus 27% in other group (p <0.05). There was a significant reduction in nausea in the diazepam group (p <0.05). A significant reduction in vomiting was observed in both groups. No side effects or congenital neonatal malformations were found in the diazepam group. Conclusions: Intravenous administration of fluids and vitamins is the standard treatment for women hospitalized for hyperemesis gravidarum. The addition of diazepam to the treatment is effective in reducing nausea and does not have teratogenic effects.

AB - Objective: Hyperemesis gravidarum is a relatively unknown disease, and is generally self-limiting. In some women the symptoms are so severe as to threaten the health of the mother and fetus. Therapies proposed for hyperemesis gravidarum are therefore rather empirical. Medical treatment includes parenteral fluid replacement and nutrition, electrolytes, antiemetics, vitamins, sedation and psychological counseling. Diazepam and benzodiazepins have been widely studied in pregnancy but the results are contradictory. The aim of the present study was to investigate the efficacy of parenteral fluids with vitamins, with or without diazepam sedation. Methods: Fifty women with hyperemesis gravidarum were enrolled in the study. They were treated with infusions of normal saline, glucose, vitamins and randomly with diazepam. Results: The results show that the mean stay in the hospital was shorter in the diazepam group: 4.5 ± 1.9 vs. 6 ± 1.6 days (p <0.05) and readmission to the the hospital was 4% in the diazepam group versus 27% in other group (p <0.05). There was a significant reduction in nausea in the diazepam group (p <0.05). A significant reduction in vomiting was observed in both groups. No side effects or congenital neonatal malformations were found in the diazepam group. Conclusions: Intravenous administration of fluids and vitamins is the standard treatment for women hospitalized for hyperemesis gravidarum. The addition of diazepam to the treatment is effective in reducing nausea and does not have teratogenic effects.

KW - Diazepam

KW - Hyperemesis gravidarum

KW - Intravenous fluid therapy

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=0032697316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032697316&partnerID=8YFLogxK

M3 - Article

C2 - 10592423

AN - SCOPUS:0032697316

VL - 48

SP - 232

EP - 236

JO - Gynecologic and Obstetric Investigation

JF - Gynecologic and Obstetric Investigation

SN - 0378-7346

IS - 4

ER -